NewLink Genetics Reports First Quarter 2016 Financial Results

NewLink Genetics Reports First Quarter 2016 Financial Results

Additionally, there are ongoing clinical development programs and data on induced immune responses targeting non-small-cell lung cancer, melanoma, prostate cancer and kidney cancer. … studies; its plans related to moving additional indications into

(Visited 3 times, 1 visits today)
1
Like
Save

Comments

Write a comment